NasdaqCM - Delayed Quote USD

Quipt Home Medical Corp. (QIPT)

3.6600 0.0000 (0.00%)
At close: April 26 at 4:00 PM EDT
3.6600 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
246,290.0000
221,742.0000
139,862.0000
102,351.0000
72,639.0000
Cost of Revenue
65,719.0000
57,897.0000
33,213.0000
28,172.0000
19,934.0000
Gross Profit
180,571.0000
163,845.0000
106,649.0000
74,179.0000
52,705.0000
Operating Expense
173,553.0000
156,980.0000
104,972.0000
75,500.0000
53,335.0000
Operating Income
7,018.0000
6,865.0000
1,677.0000
-1,321.0000
-630.0000
Net Non Operating Interest Income Expense
-9,836.0000
-8,359.0000
-3,068.0000
-1,993.0000
-2,052.0000
Other Income Expense
-905.0000
-1,205.0000
4,326.0000
-6,015.0000
-893.0000
Pretax Income
-3,723.0000
-2,699.0000
2,935.0000
-9,329.0000
-3,575.0000
Tax Provision
-28.0000
85.0000
-1,904.0000
-3,155.0000
128.0000
Net Income Common Stockholders
-3,695.0000
-2,784.0000
4,839.0000
-6,174.0000
-4,572.0000
Diluted NI Available to Com Stockholders
-3,695.0000
-2,784.0000
4,839.0000
-6,174.0000
-4,572.0000
Basic EPS
-0.09
-0.07
0.14
-0.20
-0.20
Diluted EPS
-0.09
-0.07
0.13
-0.20
-0.20
Basic Average Shares
39,533.5000
38,607.0000
34,564.2860
30,438.0000
22,721.0000
Diluted Average Shares
39,533.5000
38,607.0000
37,223.0770
30,438.0000
22,721.0000
Total Operating Income as Reported
3,920.0000
3,919.0000
4,731.0000
-1,460.0000
658.0000
Total Expenses
239,272.0000
214,877.0000
138,185.0000
103,672.0000
73,269.0000
Net Income from Continuing & Discontinued Operation
-3,695.0000
-2,784.0000
4,839.0000
-6,174.0000
-4,572.0000
Normalized Income
-2,965.5278
-1,902.3600
1,980.7800
-4,569.7792
-3,878.9300
Interest Expense
7,853.0000
6,607.0000
2,079.0000
1,993.0000
1,837.0000
Net Interest Income
-9,836.0000
-8,359.0000
-3,068.0000
-1,993.0000
-2,052.0000
EBIT
4,130.0000
3,908.0000
5,014.0000
-7,336.0000
-1,738.0000
EBITDA
49,846.0000
44,071.0000
28,054.0000
10,450.0000
12,800.0000
Reconciled Cost of Revenue
65,719.0000
57,897.0000
33,213.0000
28,172.0000
19,934.0000
Reconciled Depreciation
45,716.0000
40,163.0000
23,040.0000
17,786.0000
14,538.0000
Net Income from Continuing Operation Net Minority Interest
-3,695.0000
-2,784.0000
4,839.0000
-6,174.0000
-3,703.0000
Total Unusual Items Excluding Goodwill
-735.0000
-1,116.0000
3,618.0000
-2,424.0000
241.0000
Total Unusual Items
-735.0000
-1,116.0000
3,618.0000
-2,424.0000
241.0000
Normalized EBITDA
50,581.0000
45,187.0000
24,436.0000
12,874.0000
12,559.0000
Tax Rate for Calcs
0.0000
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-5.5278
-234.3600
759.7800
-819.7792
65.0700
9/30/2020 - 8/10/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IRIX IRIDEX Corporation
2.8700
-3.04%
 
VMD Viemed Healthcare, Inc.
8.31
+3.75%
 
EVMT.V Evome Medical Technologies Inc.
0.1950
-7.14%
 
MODD Modular Medical, Inc.
1.5800
+3.95%
 
AHCO AdaptHealth Corp.
9.96
+3.97%
 
SRTS Sensus Healthcare, Inc.
3.4100
+2.40%
 
FZMD Fuse Medical, Inc.
0.0988
0.00%
 
FZRO CS Diagnostics Corp.
0.1725
0.00%
 
AEMD Aethlon Medical, Inc.
1.3600
-10.82%
 
GTHP Guided Therapeutics, Inc.
0.0873
-12.70%